118 related articles for article (PubMed ID: 19998199)
1. Who's in control of the choice of control?
Anderson JA
Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199
[No Abstract] [Full Text] [Related]
2. A clinical perspective on placebo research: looking back, looking forward.
Dworkin RW
Am J Bioeth; 2009 Sep; 9(9):54-5. PubMed ID: 19998196
[No Abstract] [Full Text] [Related]
3. Research, medicine, and "placebos".
Moerman DE
Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201
[No Abstract] [Full Text] [Related]
4. Conflating scientific with clinical considerations.
van der Graaf R; van Delden JJ
Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198
[No Abstract] [Full Text] [Related]
5. Strengthening Howick's argument against the alleged superiority of placebo-controlled trials.
Rennie S; Stürmer T
Am J Bioeth; 2009 Sep; 9(9):62-4. PubMed ID: 19998200
[No Abstract] [Full Text] [Related]
6. Ethical issues in the difference between placebo-controlled and active-controlled trials.
Petrini C
Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197
[No Abstract] [Full Text] [Related]
7. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
Howick J
Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192
[TBL] [Abstract][Full Text] [Related]
8. Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentaries.
Howick J
Am J Bioeth; 2009 Sep; 9(9):W5-7. PubMed ID: 19998178
[No Abstract] [Full Text] [Related]
9. Distinguishing dilemmas in the ethics of placebo-controlled trials.
Kovach K
Am J Bioeth; 2002; 2(2):32-3. PubMed ID: 12189072
[No Abstract] [Full Text] [Related]
10. Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research.
Orentlicher D
Hastings Cent Rep; 2005; 35(5):20-8. PubMed ID: 16295261
[TBL] [Abstract][Full Text] [Related]
11. Placebo misconceptions.
Senn S
Am J Bioeth; 2009 Sep; 9(9):53-4. PubMed ID: 19998195
[No Abstract] [Full Text] [Related]
12. I thought we were in this together?
Trachtman H
Am J Bioeth; 2002; 2(2):30-1. PubMed ID: 12189071
[No Abstract] [Full Text] [Related]
13. Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results.
Banja JD; Dunlop B
Am J Bioeth; 2009 Aug; 9(8):39-41. PubMed ID: 19998159
[No Abstract] [Full Text] [Related]
14. Preparing for a post-placebo paradigm: ethics and choice of control in clinical trials.
Nunn R
Am J Bioeth; 2009 Sep; 9(9):51-2. PubMed ID: 19998194
[No Abstract] [Full Text] [Related]
15. The rationale for placebo-controlled trials: methodology and policy considerations.
Miller FG
Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193
[No Abstract] [Full Text] [Related]
16. The physician/investigator's obligation to patients participating in research: the case of placebo controlled trials.
Glass KC; Waring D
J Law Med Ethics; 2005; 33(3):575-85. PubMed ID: 16240737
[No Abstract] [Full Text] [Related]
17. Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution.
Golomb BA
Am J Bioeth; 2009 Sep; 9(9):67-9. PubMed ID: 19998203
[No Abstract] [Full Text] [Related]
18. Placebo controls in clinical trials of new therapies for osteoporosis.
Levine RJ
J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775
[No Abstract] [Full Text] [Related]
19. Clinical research should not be permitted to escape the ethical orbit of clinical care.
Steinberg D
Am J Bioeth; 2002; 2(2):27-8. PubMed ID: 12189069
[No Abstract] [Full Text] [Related]
20. What it takes to defend deceptive placebo use.
Barnhill A
Kennedy Inst Ethics J; 2011 Sep; 21(3):219-50. PubMed ID: 22073816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
